Syrah Resources Ltd announced for successful commissioning of the attrition cells

Syrah Resources Ltd announced - kalkine Media

Commissioned the attrition cells for the fines graphite circuit: Syrah Resources Ltd.’s (ASX:SYR) stock fell 1.946% on August 14, 2018 (3 PM AEST) though the company commissioned the attrition cells for the fines graphite circuit that is now fully operational. This is as per the plan and they are required to be fully integrated into production. Moreover, the company’s initial assessment showed significant improvement in fines graphite fixed carbon levels, which will enable improvements in both quality and recovery.

[optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

The group is now focusing on stable plant flows with better utilisation and recovery rates to help support the Balama Graphite Project operations.

SYR has also planned production of higher fixed carbon graphite product to 96%-98%, that will be driven by customer demand. SYR also expects the development of a price premium for higher carbon content products. Meanwhile, SYR stock has fallen 19.94% in three months as on August 13, 2018.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report